All In Biotech

Drug Trial Radar · NCT02793817

Safety and Efficacy of KPI-121 in Subjects With Postsurgical Inflammation and Pain

A Phase 3, Double-Masked, Randomized, Controlled Study to Evaluate the Safety and Efficacy of KPI-121 1.0% Ophthalmic Suspension in Subjects With Postsurgical Inflammation and Pain

Last checked: Nov 19, 2026Latest source record: Dec 16, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 520 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

520

Actual

Start

Jun 2016

Primary completion

Mar 2017

Study completion Mar 2017

Sponsor

Lead sponsor
Kala Pharmaceuticals, Inc.Industry
Sponsor type
Industry
First posted
Jun 8, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of the study is to investigate the efficacy and safety of KPI-121 1.0% ophthalmic suspension compared to placebo in subjects who have undergone cataract surgery.

Conditions

  • Post Surgical Ocular Inflammation and Pain

Interventions

  • KPI-121 1% Ophthalmic Suspension dosed BIDDrug

  • Vehicle of KPI-121 Ophthalmic Suspension dosed BIDDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Complete Resolution of Anterior Chamber (AC) Cells at Day 8Time frame: Visit 5 (Day 8) maintained through Visit 6 (Day 15)
  2. Complete Resolution of Ocular Pain at Day 8Time frame: Visit 5 (Day 8) maintained through Visit 6 (Day 15)

Locations

35 sites in 1 country. Site status is shown where the registry gives one.

  • Arizona Eye Center

    Chandler, Arizona

  • Cornea and Cataract Consultants of CA

    Phoenix, Arizona

  • Sall Research Medical Center

    Artesia, California

  • Orange County Ophthalmology

    Garden Grove, California

  • Lugene Eye Institute

    Glendale, California

  • Inland Eye Specialists

    Hemet, California

  • United Medical Research Institute

    Inglewood, California

  • LoBue Laser and Eye Medical Center

    Murrieta, California

  • Pendleton Eye Center

    Oceanside, California

  • North Bay Eye Associates, Inc.

    Petaluma, California

  • Arch Health Partners

    Poway, California

  • Martel Eye Medical Group

    Rancho Cordova, California

  • Shasta Eye Medical Group, Inc

    Redding, California

  • Eye Center of Northern Colorado, PC

    Fort Collins, Colorado

  • Eye Associates of Fort Myers

    Fort Myers, Florida

  • Levenson Eye Associates

    Jacksonville, Florida

  • Shettle Eye Research, Inc

    Largo, Florida

  • International Research Center

    Tampa, Florida

  • Chicago Cornea Consultants, Ltd.

    Hoffman Estates, Illinois

  • Jacksoneye, S. C.

    Lake Villa, Illinois

  • The Eye Care Institute

    Louisville, Kentucky

  • Great Lakes Eye Care

    Saint Joseph, Michigan

  • Minnesota Eye Consultants, PA

    Bloomington, Minnesota

  • Comprehensive Eye Care, Ltd. / Vision Research Institute, LLC

    Washington, Missouri

  • Abrams Eye Institute

    Las Vegas, Nevada

  • Duke University Eye Center

    Durham, North Carolina

  • Apex Eye

    Cincinnati, Ohio

  • Roseburg Research Associates, LLC

    Roseburg, Oregon

  • Eye Care Specialists

    Kingston, Pennsylvania

  • Carolina Cataract & Laser Center

    Ladson, South Carolina

  • Carolina Eyecare Physicians, LLC

    Mt. Pleasant, South Carolina

  • Texan Eye, PA / Keystone Research, Ltd

    Austin, Texas

  • The Cataract & Glaucoma Center

    El Paso, Texas

  • Houston Eye Associates

    Houston, Texas

  • Kozlovsky Delay & Winter Eye Consultants, LLC Corona Research

    San Antonio, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.